No Data
Benign Growth For Sunflower Pharmaceutical Group Co.,Ltd (SZSE:002737) Underpins Its Share Price
Sunflower Pharmaceutical Group (002737.SZ) plans to increase its capital in Linjiang Sunflower by 60 million yuan to improve its asset structure.
Sunflower pharmaceutical group (002737.SZ) announced that the company plans to use its own funds of 60 million yuan to make investments in its subsidiary.
sunflower pharmaceutical group (002737.SZ): currently includes folic acid tablets in its sales products
Gelonghui November 25th | Sunflower Pharmaceutical Group (002737.SZ) stated on the investor interaction platform that the products currently on sale by the company include folic acid tablets.
Sunflower Pharmaceutical Gets Nod to Register Ibuprofen Suspension
Sunflower Pharmaceutical Group (002737.SZ): Ibuprofen suspension has obtained the pharmaceutical registration certificate.
On November 21, Gelonghui reported that Sunflower Pharmaceutical Group (002737.SZ) announced that its subsidiary recently received the drug registration certificate issued by the National Medical Products Administration for the registration of ibuprofen suspension. The ibuprofen suspension is used for fever caused by common colds or influenza in children. It is also used to relieve mild to moderate pain in children, such as headaches, joint pain, migraines, toothaches, muscle pain, and neuralgia.
Sunflower pharmaceutical group (002737.SZ): The employee stock ownership plan shares have been sold and the plan is terminated in 2021.
Grainews November 19th | Sunflower Pharmaceutical Group (002737.SZ) announced that as of the announcement date, the company's stocks held by the 2021 employee stock ownership plan totaling 4.18 million shares have been completely sold on the secondary market through centralized bidding trading, accounting for 0.72% of the company's total share capital. According to the relevant regulations of the company's 2021 employee stock ownership plan, this employee stock ownership plan has been completed and terminated in advance, and subsequent work such as asset liquidation and distribution will be carried out.
Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Stock Has Fared Decently: Is the Market Following Strong Financials?
